1298 related articles for article (PubMed ID: 27920515)
1. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
Tang H; Fang Z; Saborío GP; Xiu Q
Lung; 2015 Aug; 193(4):513-9. PubMed ID: 26044556
[TBL] [Abstract][Full Text] [Related]
3. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
4. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
Meister R; Wittig T; Beuscher N; de Mey C
Arzneimittelforschung; 1999 Apr; 49(4):351-8. PubMed ID: 10337455
[TBL] [Abstract][Full Text] [Related]
6. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
7. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
Cazzola M; Floriani I; Page CP
Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis.
Monz BU; Sachs P; McDonald J; Crawford B; Nivens MC; Tetzlaff K
Respir Med; 2010 Apr; 104(4):534-41. PubMed ID: 19917525
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
[TBL] [Abstract][Full Text] [Related]
11. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
Solèr M; Mütterlein R; Cozma G;
Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
[TBL] [Abstract][Full Text] [Related]
12. [The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis].
Pirozyński M; Skucha W; Słomiński M; Chyczewska E; Malinowski J; Nowak D; Bartmińiski W; Pachocki R;
Pol Merkur Lekarski; 2005 Aug; 19(110):139-43. PubMed ID: 16245418
[TBL] [Abstract][Full Text] [Related]
13. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial.
Johnson K; McEvoy CE; Naqvi S; Wendt C; Reilkoff RA; Kunisaki KM; Wetherbee EE; Nelson D; Tirouvanziam R; Niewoehner DE
Int J Chron Obstruct Pulmon Dis; 2016; 11():799-807. PubMed ID: 27143871
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
Wedzicha JA; Buhl R; Lawrence D; Young D
Respir Med; 2015 Jan; 109(1):105-11. PubMed ID: 25433954
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
16. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD.
Matthys H; Pliskevich DA; Bondarchuk OM; Malek FA; Tribanek M; Kieser M
Respir Med; 2013 May; 107(5):691-701. PubMed ID: 23478193
[TBL] [Abstract][Full Text] [Related]
17. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).
Celli B; Halpin D; Hepburn R; Byrne N; Keating ET; Goldman M
Respir Med; 2003 Jan; 97 Suppl A():S35-43. PubMed ID: 12564609
[TBL] [Abstract][Full Text] [Related]
18. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis.
Lee JS; Park DA; Hong Y; Jo KW; Lee SW; Huh JW; Oh YM; Lee SD
Int J Tuberc Lung Dis; 2013 Feb; 17(2):153-62. PubMed ID: 23317949
[TBL] [Abstract][Full Text] [Related]
20. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
